Patents Assigned to The Wellcome Foundation Limited
  • Publication number: 20020164788
    Abstract: The present invention relates to a monoclonal antibody, preferably with specificity for CD38, having CDRs of foreign origin and a recipient framework region having a sequence of human or primate origin, wherein the original amino acid residues in position 29 and/or 78 of the sequence of the recipient framework region of the heavy chain is replaced by a replacement amino acid residue that is the same or similar to that in the corresponding position of the sequence of the corresponding framework region of the heavy chain of the antibody from which the CDRs are derived. The invention also relates to a method of preparation of the antibody, a pharmaceutical composition containing the antibody and a method of using the antibody for the treatment of cancer and autoimmune diseases.
    Type: Application
    Filed: March 5, 2001
    Publication date: November 7, 2002
    Applicant: THE WELLCOME FOUNDATION LIMITED
    Inventors: Jonathan Henry Ellis, Alan Peter Lewis
  • Patent number: 5861179
    Abstract: The present invention relates to a pharmaceutical formulation of lamotrigine, pharmaceutically acceptable salts thereof and the preparation of such a formulation.
    Type: Grant
    Filed: June 26, 1997
    Date of Patent: January 19, 1999
    Assignee: The Wellcome Foundation Limited
    Inventors: Simon Philip Hiskett, Susan Ann Taylor
  • Patent number: 5744466
    Abstract: Compounds of formula (I) ##STR1## wherein R and R.sup.1 are hydrogen, C.sub.1-4 alkyl or are linked to form a ring,A is a cycloalkyl or alkyl-cycloalkyl group,n is an integer from 0 to 3,W is an optionally substituted 5-or 6-membered heterocyclic ring; or W is an optionally substituted aryl, heteroaryl, aryloxy or thiophenoxy group; orW is a group --SO.sub.2 NR.sup.6 R.sup.7 --NHC(O)R.sup.6 R.sup.7 or --C(O)NHR.sup.6 R.sup.7 ;are useful in treating clinical conditions for which a "5-HT.sub.1 -like" receptor agonist is indicated.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: April 28, 1998
    Assignee: The Wellcome Foundation Limited
    Inventors: Robert Charles Glen, David Lawrence Selwood, Graeme Richard Martin, Christopher James Foster
  • Patent number: 5717086
    Abstract: 2',3'-Dideoxy-3'-fluorouridines are made by reaction of a corresponding anhydronucleoside with hydrogen fluoride in the presence of an organo-iron compound.
    Type: Grant
    Filed: February 14, 1996
    Date of Patent: February 10, 1998
    Assignees: Rhone-Poulenc Chemicals Limited, The Wellcome Foundation Limited
    Inventors: Owen Ross Chambers, Patrick Charles Youmans, Andrew Lawrence Germain
  • Patent number: 5527529
    Abstract: The present invention discloses a novel approach to attenuating bacteria and for their use as live vaccines. The vaccines can be used in human and animal medicine.In particular, there is disclosed a method of attenuating a bacteria by mutating a gene concerned with the regulation of one or more genes concerned with expression of outer membrane proteins, particularly porin proteins.
    Type: Grant
    Filed: April 10, 1995
    Date of Patent: June 18, 1996
    Assignees: The Wellcome Foundation Limited, The Royal Society, The Lister Institute of Preventive Medicine, The University Court of The University of Dundee
    Inventors: Gordan Dougan, Steven N. Chatfield, Christopher F. Higgins, Charles J. Dorman
  • Patent number: 5342616
    Abstract: The use of bolus injections of t-PA in the treatment of human beings with a thrombotic disorder.
    Type: Grant
    Filed: December 16, 1992
    Date of Patent: August 30, 1994
    Assignee: The Wellcome Foundation Limited
    Inventor: Adam F. Cohen
  • Patent number: 5330977
    Abstract: The invention relates to N-deacetyl-lysogangliosides and physiologically acceptable salts thereof, especially those of formula (I): ##STR1## wherein R represents --CH.dbd.CH(CH.sub.2)nCH.sub.3 or --CH.sub.2 CH.sub.2 (CH.sub.2)nCH.sub.3 ;n is 12 or 14;R.sup.1 represents ##STR2## or hydrogen; and R.sup.2 represents hydrogen or acetyl; for use in therapy.The compounds are useful as inhibitors of phospholipases A.sub.2, and of superoxide production, as antiproliferative and immunosuppressant agents and in the treatment of autoimmune diseases. The invention also relates to the use of N-deacetyl-lysogangliosides for the manufacture of medicaments for the treatment of the aforementioned conditions.
    Type: Grant
    Filed: July 27, 1992
    Date of Patent: July 19, 1994
    Assignee: The Wellcome Foundation Limited
    Inventors: Ezio Tubaro, Giovanni Cavallo
  • Patent number: 5281702
    Abstract: The invention relates to N-deacetyl-lysogangliosides and physiologically acceptable salts thereof, especially those of formula (I): ##STR1## wherein R represents --CH.dbd.CH(CH.sub.2)nCH.sub.3 or --CH.sub.2 CH.sub.2 (CH.sub.2)nCH.sub.3 ;n is 12 or 14;R.sup.1 represents ##STR2## or hydrogen; and R.sup.2 represents hydrogen or acetyl; for use in therapy.The compounds are useful as inhibitors of phospholipases A.sub.2, and of superoxide production, as antiproliferative and immunosuppressant agents in the treatment of autoimmune diseases. The invention also relates to the use of N-deacetyl-lysogangliosides for the manufacture of medicaments for the treatment of the aforementioned conditions.
    Type: Grant
    Filed: June 18, 1991
    Date of Patent: January 25, 1994
    Assignee: Wellcome Foundation Limited
    Inventors: Ezio Tubaro, Giovanni Cavallo
  • Patent number: 5229424
    Abstract: The present invention discloses pesticidally active compounds of formula (II) ##STR1## or a salt thereof, wherein Q is a monocylcic aromatic ring, or fused bicyclic ring system of which at least one ring is aromatic containing 9 or 10 atoms of which one may be nitrogen and the rest carbon each ring system being optionally substituted, or Q is a dihalovinyl group or a group R.sup.6 --C.tbd.C-- where R.sup.6 is C.sub.1-4 alkyl, tri C.sub.1-4 alkylsilyl, halogen or hydrogen; R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are the same or different with at least one being hydrogen and the others being independently selected from hydrogen, halo, C.sub.1-4 alkyl or C.sub.1-4 haloalkyl; and R.sup.1 is selected from hydrogen and C.sub.1-8 hydrocarbyl optionally substituted by dioxalanyl, halo, cyano, trifluoromethyl, trifluoromethylthio or C.sub.1-6 alkoxy and X.sup.1 is hydrogen, fluoro or chloro.
    Type: Grant
    Filed: February 14, 1992
    Date of Patent: July 20, 1993
    Assignee: The Wellcome Foundation Limited
    Inventors: Robert J. Blade, George S. Cockerill, John E. Robinson
  • Patent number: 5202356
    Abstract: The present Application discloses pesticidally active compounds of the formula (I):Q Q.sup.1 CR.sup.2 =CR.sup.3 CR.sup.4 =CR.sup.5 C (.dbd.X) NHR.sup.1or a salt thereof, wherein Q is an monocyclic aromatic ring. or fused bicyclic ring system of which at least one ring is aromatic containing 9 or 10 atoms of which one may be nitrogen and the rest carbon each optionally substituted, or Q is a dihalovinyl group or a group R.sup.6 --C.tbd.C-- where R.sup.6 is C.sub.1-4 alkyl, tri C.sub.1-4 alkylsilyl, halogen or hydrogen; Q.sup.1 is a 1,2-cyclopropyl ring optionally substituted by one or more groups selected from C.sub.1-3 alkyl. halo, C.sub.1-3 haloalkyl, alkynyl, or cyano; R.sup.2,R.sup.3, R.sup.4 and R.sup.5 are the same or different with at least one being hydrogen and the others being independently selected from hydrogen, halo. C.sub.1-4 alkyl or C.sub.1-4 haloalkyl; X is oxygen or sulphur; and R.sup.1 is selected from hydrogen and C.sub.
    Type: Grant
    Filed: July 12, 1991
    Date of Patent: April 13, 1993
    Assignee: The Wellcome Foundation Limited
    Inventors: Robert J. Blade, George S. Cockerill, John E. Robinston
  • Patent number: 5162367
    Abstract: Insecticidal and acaricidal compounds of FormulaAR(CH.sub.2).sub.x O(CH.sub.2).sub.m A(CH.sub.2).sub.n (CE.sup.1 =CE.sup.2).sub.a (CE.sup.3 =CE.sup.4)CONR.sup.1 R.sup.2 (I)whereinAr is phenyl or naphthyl, in either case optionally substituted by one or more of optionally substituted C.sub.1-6 alkyl, optionally substituted C.sub.1-6 -alkylthio or C.sub.1-6 alkylthiooxy, halogen or optionally substituted C.sub.1-6 alkoxy,x=0 or 1m=1 to 7n=1 to 7A=CH.sub.2 or oxygena=0 or 1R.sup.1 and R.sup.2 are independently selected from hydrogen, C.sub.1-6 alkyl and C.sub.3-6 cycloalkyl (either of which may be substituted by one or more of halo, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, CF.sub.2-6 alkoxy, C.sub.2-6 alkynyl, dioxalanyl and C.sub.3-6 cycloalkyl)E.sup.1, E.sup.2, E.sup.3 and E.sup.4 are independently selected from hydrogen, C.sub.1-4 alkyl, optionally substituted by halo, and nitrile, provided that at least one of E.sup.1, E.sup.2, E.sup.3 and E.sup.
    Type: Grant
    Filed: October 23, 1989
    Date of Patent: November 10, 1992
    Assignee: The Wellcome Foundation Limited
    Inventors: Robert J. Blade, John E. Robinson
  • Patent number: 5150822
    Abstract: An apparatus for dispersing an active ingredient, such as a fumigant, fertilizer or room freshener in which the active ingredient is placed in a sample cylinder and a pressurized solvent/propellent is subsequently introduced from a source. The solvent/propellent expands to adopt a liquid phase and a gaseous phase. The liquid phase serves to absorb the active ingredient and the gaseous phase serves to propel the borne active ingredient out of the apparatus through a dispensing outlet where further expansion takes place and the active ingredient is dispersed in a fog or mist. Flow restrictors create a pressure differential between the sample cylinder outlet and a by-pass portion to enable total absorption of the active ingredient. The flow restrictors and conduits for the system are contained in a mixing head for the sample cylinder.
    Type: Grant
    Filed: January 30, 1991
    Date of Patent: September 29, 1992
    Assignee: The Wellcome Foundation Limited
    Inventors: Joseph G. Eitner, Jr., Robert J. Tice, Jr.
  • Patent number: 5129566
    Abstract: An ampoule holder comprises a body part 1 and a head part 2 which are connected together by a pair of hinge strips 3 and a breakage link 4. A glass ampoule 7 is inserted, stem first, through an opening 6 in the base of the body portion 1. The body of the ampoule is forced past inwardly extending projections 8 until the lower end of the ampoule snaps past these projections and the shoulder at the top of the body of the ampoule 7 abuts against the curved hinge parts 3. The base of the ampoule will then be raised above the projections 8. The stem 10 of the ampoule is gripped within the head portion 2 of the holder by internal ribs or spines 11, so that the neck 9 of the ampoule is aligned with the breakage link 4.
    Type: Grant
    Filed: January 18, 1991
    Date of Patent: July 14, 1992
    Assignee: The Wellcome Foundation Limited
    Inventors: Brian L. Ogden, Christopher J. Griffin, Nicholas B. Verbelyi, Gerard M. O'Brien
  • Patent number: 5116862
    Abstract: The present invention provides a class of novel substituted bicyclooctanes which have pesticidal activity, particularly against arthropod pests. Pesticidal formulations containing the compounds of the formula (I), their use in the control of pests and methods for their preparation are also disclosed.
    Type: Grant
    Filed: July 21, 1988
    Date of Patent: May 26, 1992
    Assignee: The Wellcome Foundation Limited
    Inventors: John B. Weston, John P. Larkin, Ian H. Smith
  • Patent number: 5098929
    Abstract: A compound of the formula (I): ##STR1## wherein R is C.sub.2-10 alkyl, alkenyl or alkynyl, each optionally subsituted by or methyl substituted by cyano, C.sub.3-4 cycloalkyl, halo, C.sub.1-4 alkoxy or a group S(O)mR.sup.4 where R.sup.4 is C.sub.1-4 alkyl and m is O, 1 or 2, or R is C.sub.3-10 cycloalkyl, C.sub.4-10 cycloalkenyl or phenyl, each optionally substituted by C.sub.1-4 alkoxy, C.sub.1-3 alkyl, C.sub.2-4 alkynyl, halo, cyano or a group S(O)mR.sup.4 as defined hereinbefore; R.sup.1 is halo, C.sub.1-3 alkyl, C.sub.2-3 alkenyl or alkynyl each optionally substituted by halo, cyano, C.sub.1-4 alkoxy, alkyl carbalkoxy containing up to 6 carbon atoms, a group S(O)mR.sup.4 as defined hereinbefore or alkynyl substituted by tri-C.sub.1-4 alkylsilyl, or R.sup.1 is cyano, spiro-cyclopropyl, gem dimethyl, oxo or methylene optionally substituted by cyano or C.sub.1-3 alkyl optionally substituted by fluorine, or R.sup.1 and R and the carbon atoms to which they are attached form a C.sub.
    Type: Grant
    Filed: February 9, 1990
    Date of Patent: March 24, 1992
    Assignee: The Wellcome Foundation Limited
    Inventors: John P. Larkin, Ian H. Smith
  • Patent number: 5057504
    Abstract: Pesticidal bicyclo-octanes are of the formula ##STR1## where R is a substituted or unsubstituted aliphatic or aromatic group, R' and R.sup.3 are H or a substituted or unsubstituted aliphatic or aromatic group, R.sup.2 is a substituted or unsubstituted heterocyclic group containing at least one ring nitrogen and is preferably a 3- or 4- pyridyl group, Z is CH.sub.2 CH.sub.2, CH.sub.2 O--CH.sub.2 S or COCH.sub.2 or CH(OR.sup.5)CH.sub.2 where R.sup.5 is H, alkyl, acyl or carbamoyl at Y and Y' are O or S(O).sub.m where m is 0, 1 or 2.Various methods for their preparation are described.
    Type: Grant
    Filed: August 16, 1989
    Date of Patent: October 15, 1991
    Assignee: The Wellcome Foundation Limited
    Inventors: Malcolm H. Black, John A. Wyatt, John B. Weston, John P. Larkin, Ian H. Smith, David A. Pulman
  • Patent number: 5026874
    Abstract: The present invention provides compounds of the formula (I): ##STR1## wherein R is a C.sub.2-10 non-aromatic hydrocarbyl group, a C.sub.2-10 non-aromatic hydrocarbyl group substituted by, or methyl substituted by cyano, halo, C.sub.1-4 alkoxy, C.sub.1-4 alkoxy substituted by halo, or a group S(O).sub.m R.sup.4 where R.sup.4 is C.sub.1-4 alkyl optionally substituted by halo and m is 0, 1 or 2, or R is phenyl or phenyl substituted by C.sub.1-4 alkoxy, C.sub.1-3 alkyl, C.sub.2-4 alkynyl, halo, C.sub.1-4 haloalkyl, cyano or a group S(O).sub.m R.sup.4 as defined hereinbefore;R.sup.1 and R.sup.2 may be the same or different, and each is hydrogen, or a C.sub.1-3 aliphatic group, or a C.sub.1-3 aliphatic group substituted by halo; R.sup.3 contains between 3 and 18 carbon atoms and is a group R.sup.5 wherein R.sup.5 is a C.sub.1-13 non-aromatic hydrocarbyl group, a C.sub.1-3 non-aromatic hydrocarbyl group substituted by a C.sub.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: June 25, 1991
    Assignee: Wellcome Foundation Limited
    Inventors: John P. Larkin, John A. Wyatt, Deborah J. Hawkes
  • Patent number: 5020689
    Abstract: The invention is concerned with a method and apparatus for dispersing an active ingredient, such as a fumigant. The active ingredient is placed in a container and a pressurized solvent/propellent is subsequently introduced. The solvent/propellent expands to adopt a liquid phase and a gaseous phase. The liquid phase serves to absorb the active ingredient and the gaseous phase serves to propel the borne active ingredient out of the apparatus where further expansion takes place and the active ingredient is dispersed in a fog or mist.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: June 4, 1991
    Assignee: The Wellcome Foundation Limited
    Inventors: Joseph G. Eitner, Jr., Robert J. Tice, Jr.
  • Patent number: 4997239
    Abstract: A towel-dispensing cabinet has a loop of towel web (1) available for a user, a substantial part (12) of the loop being removably contained within the cabinet. The length of exposed web (between C and D) can be increased by a user drawing web material from the concealed loop part (12) against the urging of a gravity-urged roller (9).
    Type: Grant
    Filed: February 16, 1990
    Date of Patent: March 5, 1991
    Assignee: The Wellcome Foundation Limited
    Inventors: David J. Crisp, Clive A. Roux
  • Patent number: D340519
    Type: Grant
    Filed: April 2, 1991
    Date of Patent: October 19, 1993
    Assignee: The Wellcome Foundation Limited
    Inventors: Brian L. Ogden, Christopher J. Griffin, Nicholas B. Verebelyi, Gerard M. O'Brian